“Zoledr0nic Acid May Enhance the Doxorubicin Cytotoxicity Effect in Osteosarcoma Cell Line”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 310–316, Oct. 2022, doi: 10.47750/pnr.2022.13.04.037.